Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02316262 · ClinicalTrials.gov registry record · NA
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02316262 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 33 participants.
The verdict
NCT02316262, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Subjects are being asked to participate in this study because they have an arm or leg amputation and have developed pain related to a neuroma (an ongoing localized pain related to a cut nerve ending). The investigators are studying how targeted reinnervation (TR) helps to both treat neuroma pain and to have increased prosthetic control. This surgery connects these cut nerve endings to nerves going into nearby nonfunctional muscles. This surgery was developed to allow amputees to have better prosthesis control. By chance, neuroma pain improved significantly with TR. The investigators, therefore, are conducting this clinical trial. The investigators will ask all participants to fill out a questionnaire both before and after surgery. This will help us understand how a neuroma affects the quality of life of amputee will allow us to understand how to best improve neuroma pain and prosthesis control. In order to confirm the presence and location of the neuroma before surgery, a magnetic resonance image (MRI) will be performed. Taking these pictures requires subjects to lie still for a short period of time but does not involve any invasive procedures.
Interventions
- PROCEDURE Targeted Muscle Reinnervation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02316262
The ClinicalTrials.gov registry entry for NCT02316262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Targeted Muscle Reinnervation is the first listed.
NCT02316262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02316262 about?
NCT02316262 is a clinical study titled "Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation". Subjects are being asked to participate in this study because they have an arm or leg amputation and have developed pain related to a neuroma (an ongoing localized pain related to a cut nerve ending). The investigators are studying how targeted reinnervation (TR) helps to both treat neuroma pain an...
What is the current status of trial NCT02316262?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2014-10. Estimated completion is 2018-01-01.
What interventions are being tested in trial NCT02316262?
The interventions under investigation include: Targeted Muscle Reinnervation (PROCEDURE).
Who is sponsoring clinical trial NCT02316262?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.